I interviewed Dr Danny Meyersfeld, CEO of DNAlysis Biotechnology in South Africa and according to him, variations in our DNA, which is the blueprint for our individuality, have a significant impact on our response to medication. Specific genes are involved in the metabolism of pharmaceutical drugs. We now have the test (Medcheck™) to determine the safest and most effective drug available to us.